|
SVIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.250250E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.603600E-02 |
| Normal-vs-Stage2 |
1.809510E-02 |
| Normal-vs-Stage3 |
9.421700E-03 |
| Normal-vs-Stage4 |
3.963700E-03 |
| Stage1-vs-Stage2 |
2.790000E-01 |
| Stage1-vs-Stage3 |
2.149400E-01 |
| Stage1-vs-Stage4 |
1.315040E-01 |
| Stage2-vs-Stage3 |
8.886800E-01 |
| Stage2-vs-Stage4 |
7.761800E-01 |
| Stage3-vs-Stage4 |
6.321400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.498500E-03 |
| Normal-vs-AfricanAmerican |
4.205400E-01 |
| Normal-vs-Asian |
3.361700E-02 |
| Caucasian-vs-AfricanAmerican |
3.271200E-01 |
| Caucasian-vs-Asian |
9.698200E-01 |
| AfricanAmerican-vs-Asian |
3.816600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.381400E-04 |
| Normal-vs-Female |
5.216400E-02 |
| Male-vs-Female |
8.836500E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.855700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.523880E-02 |
| Normal-vs-Age(61-80Yrs) |
3.017800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.520300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.436200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.280190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.445200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.755200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.643600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.575600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.239600E-01 |
| Classical-VS-Follicular |
9.686600E-01 |
| Classical-VS-Other |
6.362800E-01 |
| Classical-VS-Normal |
2.068400E-02 |
| Tall-VS-Follicular |
7.003400E-01 |
| Tall-VS-Other |
8.392000E-01 |
| Tall-VS-Normal |
4.678500E-02 |
| Follicular-VS-Other |
7.431400E-01 |
| Follicular-VS-Normal |
7.720200E-02 |
| Other-VS-Normal |
1.841180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.724070E-02 |
| Normal-vs-N1 |
3.689900E-02 |
| N0-vs-N1 |
9.464200E-01 |
|
|
